WIDE MOAT STOCKS COMPARISON

Checking

 

Stock Comparison

Merck & Co., Inc. vs Sanofi

Compare moat strength, market structure, and segment coverage to understand how each company defends its edge.

Merck & Co., Inc.

MRK · New York Stock Exchange

Market cap (USD)$365B
Gross margin (TTM)71.8%
Operating margin (TTM)8.1%
Net margin (TTM)3.6%
SectorHealthcare
IndustryPharmaceuticals
CountryUS
Data as of2026-08-23
83/100
Moat score

Weighted across the company's segments.

Full stock profile

Dive deeper into Merck & Co., Inc.'s moat claims, evidence, and risks.

View MRK analysis

Sanofi

SAN · Euronext Paris

Market cap (USD)$115.7B
Gross margin (TTM)73.4%
Operating margin (TTM)12.7%
Net margin (TTM)8.1%
SectorHealthcare
IndustryPharmaceuticals
CountryFR
Data as of2026-08-23
66/100
Moat score

Weighted across the company's segments.

Full stock profile

Dive deeper into Sanofi's moat claims, evidence, and risks.

View SAN analysis

Comparison highlights

  • Moat score gap: Merck & Co., Inc. leads (83 / 100 vs 66 / 100 for Sanofi).
  • Segment focus: Merck & Co., Inc. has 2 segments (89.4% in Pharmaceutical); Sanofi has 3 segments (81.8% in Pharma (Prescription Medicines)).
  • Primary market structure: Competitive vs Oligopoly. Pricing power: Moderate vs Moderate.
  • Moat breadth: Merck & Co., Inc. has 3 moat types across 3 domains; Sanofi has 3 across 3.

Primary market context

Merck & Co., Inc.

Pharmaceutical

Market

Branded prescription pharmaceuticals & human vaccines

Geography

Global

Customer

Wholesalers/retailers, managed care and government payers, hospitals/clinics

Role

R&D-intensive innovator, manufacturer, and marketer

Revenue share

89.4%

Sanofi

Pharma (Prescription Medicines)

Market

Branded prescription pharmaceuticals (immunology, rare disease, neurology, oncology, general medicines)

Geography

Global

Customer

Patients via payers/providers and channel partners (wholesalers, pharmacies, hospitals)

Role

Research-based drug developer, manufacturer, and marketer

Revenue share

81.8%

Side-by-side metrics

Merck & Co., Inc.
Sanofi
Ticker / Exchange
MRK - New York Stock Exchange
SAN - Euronext Paris
Market cap (USD)
$365B
$115.7B
Gross margin (TTM)
71.8%
73.4%
Operating margin (TTM)
8.1%
12.7%
Net margin (TTM)
3.6%
8.1%
Sector
Healthcare
Healthcare
Industry
Pharmaceuticals
Pharmaceuticals
HQ country
US
FR
Primary segment
Pharmaceutical
Pharma (Prescription Medicines)
Market structure
Competitive
Oligopoly
Market share
n/a
n/a
HHI estimate
n/a
n/a
Pricing power
Moderate
Moderate
Moat score
83 / 100
66 / 100
Moat domains
Legal, Supply, Demand
Legal, Supply, Demand
Last update
2026-09-05
2026-09-05

Moat coverage

Shared moat types

IP Choke Point

Merck & Co., Inc. strengths

Scope EconomiesData Workflow Lockin

Sanofi strengths

Capex Knowhow ScaleBrand Trust

Segment mix

Merck & Co., Inc. segments

Full profile >

Pharmaceutical

Competitive

89.4%

Animal Health

Oligopoly

9.8%

Sanofi segments

Full profile >

Pharma (Prescription Medicines)

Oligopoly

81.8%

Vaccines

Oligopoly

18.2%

Opella (Consumer Healthcare - Sanofi minority stake)

Competitive

0%

Act on this comparison

Want the full wide moat stocks list?

Browse the full ranking of wide moat stocks, updated with moat scores and segment context.

View the moat stocks list

Curation & Accuracy

This directory blends AI‑assisted discovery with human curation. Entries are reviewed, edited, and organized with the goal of expanding coverage and sharpening quality over time. Your feedback helps steer improvements (because no single human can capture everything all at once).

Details change. Pricing, features, and availability may be incomplete or out of date. Treat listings as a starting point and verify on the provider’s site before making decisions. If you spot an error or a gap, send a quick note and I’ll adjust.